AbCellera Biologics Inc. (ABCL)

NASDAQ

$12.86

$+0.76

(+6.51%)

Regular Market

AbCellera Biologics Inc. (ABCL) Live Price Chart

Last updated: ⁦2026-09-17 14:28:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

AbCellera Biologics Inc. (ABCL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.86, with a market capitalization of $3.70B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.75 to $12.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.70B
Open	$12.15
Day's High	$71.91
Day's Low	$1.89
Previous Close	$11.67
Volume	2.21M
Average Volume	7.45M
P/E Ratio	--
52-Week High	$12.91
52-Week Low	$2.75
Dividend Yield	--
Earnings Date	--

AbCellera Biologics Inc. (ABCL) Stock Price Today

AbCellera Biologics Inc. (ABCL) is currently trading at $12.86 as of 2026-09-17 14:12:56, up 10.19% ($1.19) from the previous close of $11.67

During today's regular trading session, ABCL has traded between $1.89 and $71.91, with a trading volume of 2.21M shares. The current price is near the lower end of today's range.

AbCellera Biologics Inc. (ABCL) 7-Day Stock Price Change

Over the past seven days, AbCellera Biologics Inc. (ABCL) moved from $11.44 to $12.86, representing a gain of 12.40% ($1.42).

The stock traded between $10.32 and $12.91 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 3.86 million shares, down versus the previous seven-day period, indicating lower trading activity.

ABCL 52-Week Price Position

Position in Range: 99.5%

52W Low$2.75

52W High$12.91

ABCL is currently trading at $12.86, placing it 99.5% of the way from its 52-week low of $2.75 to its 52-week high of $12.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AbCellera Biologics Inc. (ABCL)?

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

AbCellera Biologics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	562
Exchange	NASDAQ
Company Website	https://www.abcellera.com

How to Buy AbCellera Biologics Inc. (ABCL) Stock on MEXC

Eligible investors can buy real shares of AbCellera Biologics Inc. (ABCL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ABCL and Place Your Order

Open the RealStocks trading page and search for ABCL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AbCellera Biologics Inc. (ABCL) stock price today?

AbCellera Biologics Inc. (ABCL) is currently trading at $ 12.86, up 10.19% ($1.19) from the previous close of $ 11.67. Intraday prices update in real time during regular trading hours.

2.Is ABCL stock going up or down today?

As of 2026-09-17 14:12:56, ABCL is trading at $ 12.86, up 10.19% ($1.19) from its previous close of $ 11.67. The stock has traded between $ 1.89 and $ 71.91 during today’s regular session. Past price movements do not guarantee future results.

3.What is ABCL pre-market price?

As of 2026-09-17 14:12:56, ABCL is trading at $ 12.08 in pre-market trading, up 3.47% ($0.40) from the previous close of $ 11.67. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ABCL after-hours price?

As of 2026-09-17 14:12:56, ABCL is trading at $ 11.69 in after-hours trading, up 0.20% ($0.02) from the regular-session close of $ 11.67. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ABCL stock trading now?

ABCL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ABCL sit relative to its 52-week high and low?

Over the past 52 weeks, ABCL has traded between a low of $ 2.75 and a high of $ 12.91. At $ 12.86, the stock is positioned 99.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AbCellera Biologics Inc. in?

AbCellera Biologics Inc. (ABCL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AbCellera Biologics Inc.'s market capitalization and where is it listed?

AbCellera Biologics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.70B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ABCL valued in terms of P/E ratio and EPS?

ABCL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.51. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AbCellera Biologics Inc. pay a dividend?

AbCellera Biologics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.